Glow Stack (BPC-157, TB-500, GHK-Cu)
A recovery base of BPC-157 and TB-500, plus GHK-Cu for skin and tissue support.
Not available yet · be first to know when it launches
Glow Stack (BPC-157, TB-500, GHK-Cu)
The Glow Stack adds GHK-Cu, a copper peptide explored for skin and tissue health, to the BPC-157 and TB-500 recovery base, pairing bounce-back support with the appearance side of feeling like yourself.
What it may help support
- Recovery and tissue support (explored)
- Skin and tissue support via GHK-Cu (explored)
Delivery
Combination peptide therapy, considered and guided by a clinician for eligible patients.
Is it right for you?
People focused on recovery who also care about skin health, including those navigating menopause. See the Glow Stack guide.
An honest word on the evidence
The peptides in this stack are popular ahead of the long-term human research, particularly for skin and recovery claims. We keep it clinician-led, with quality sourcing and realistic expectations. Results vary.
How it works here
Every plan follows one path. Each step feeds the next. See the Glow Stack approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Frequently asked questions
BPC-157 and TB-500 for recovery, plus GHK-Cu, a copper peptide explored for skin and tissue health.
GHK-Cu is explored for skin support, but evidence varies and results are individual. We set realistic expectations.
It adds GHK-Cu for skin support on top of the recovery base.
Often considered alongside
Glow Stack (BPC-157, TB-500, GHK-Cu) is on the way
We're finalizing this treatment now. Join the waitlist and we'll email you the moment it's available — no spam, just the launch.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.